These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 23061703)

  • 21. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
    Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
    Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study.
    Sinha SD; Sinha SK; Talluri L; Bhashyakarla RK; Malladi U; Dosi RV; Jain MK; Chary S; Reddy M; Thakur P
    Cureus; 2021 Apr; 13(4):e14361. PubMed ID: 33968542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia.
    Du Y; Su T; Song X; Gao J; Zou D; Zuo C; Xie W; Wang B; Zhang Z; Xu J; Tian D; Luo H; Zhang Z; Wang S; Chen J; Guo J; Gong L; Ding Y; Li Z
    J Clin Gastroenterol; 2014 Apr; 48(4):328-35. PubMed ID: 24440931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
    Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
    J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional dyspepsia: outcome of focus groups for the development of a questionnaire for symptom assessment in patients suffering from postprandial distress syndrome (PDS).
    Carbone F; Holvoet L; Vandenberghe A; Tack J
    Neurogastroenterol Motil; 2014 Sep; 26(9):1266-74. PubMed ID: 25130784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis.
    Xiao G; Xie X; Fan J; Deng J; Tan S; Zhu Y; Guo Q; Wan C
    ScientificWorldJournal; 2014; 2014():541950. PubMed ID: 25197703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acotiamide: first global approval.
    Nowlan ML; Scott LJ
    Drugs; 2013 Aug; 73(12):1377-83. PubMed ID: 23881665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs for functional dyspepsia.
    Tack J; Janssen P
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):283-92. PubMed ID: 21413902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial distress syndrome: stratification and management.
    Van Den Houte K; Carbone F; Tack J
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):37-46. PubMed ID: 30791841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome.
    Di Stefano M; Miceli E; Tana P; Mengoli C; Bergonzi M; Pagani E; Corazza GR
    Am J Gastroenterol; 2014 Oct; 109(10):1631-9. PubMed ID: 25199472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic options for functional dyspepsia.
    Vanheel H; Tack J
    Dig Dis; 2014; 32(3):230-4. PubMed ID: 24732188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
    Funaki Y; Ogasawara N; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Sasaki M; Kasugai K
    Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.
    Tack J; Talley NJ
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):134-41. PubMed ID: 23399526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
    Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of acotiamide on gastric emptying in healthy adult humans.
    Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
    Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial symptoms originating from the stomach in functional dyspepsia.
    Vanheel H; Vanuytsel T; Van Oudenhove L; Farré R; Verbeke K; Tack J
    Neurogastroenterol Motil; 2013 Nov; 25(11):911-e703. PubMed ID: 23992049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.